Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AbbVie's $55B deal for Shire is officially dead. Now what?
Fierce Biotech
Tuesday, October 21, 2014 - 9:26am
tags:
AbbVie, Shire, M&A
Revalesio’s Drug Has Potential to Treat Alzheimer’s Disease
Drug Discovery and Development
Tuesday, October 21, 2014 - 9:25am
tags:
Revalesio, Alzheimer's disease, RNS60
Actelion Reports Strong Q3 Results, Says It Has Not Received Any Acquisition Offers From US Pharma Giants
Bidness Etc.
Tuesday, October 21, 2014 - 9:22am
tags:
Actelion, earnings
3 Drugs Critical to Johnson & Johnson's Future
Motley Fool
Tuesday, October 21, 2014 - 9:20am
tags:
JNJ, Olysio, Zytiga, Invega Sustenna, Xarelto, Stelara
MannKind Corporation's Investors Shouldn't Dance Around This Issue
Motley Fool
Tuesday, October 21, 2014 - 9:18am
tags:
MannKind, Dance Biopharm
Omeros suspends OMS824 trial in Huntington's Disease
Seeking Alpha
Tuesday, October 21, 2014 - 9:14am
tags:
Omeros, OMS824, Huntington's disease
Viagra Protects The Heart -- Now What?
Forbes
Tuesday, October 21, 2014 - 9:11am
tags:
Viagra, heart failure
AbbVie CEO Gonzalez loses Shire, but wins praise for gusty move
Reuters
Tuesday, October 21, 2014 - 8:16am
tags:
AbbVie, Pharma CEOs, Richard Gonzalez, Shire, M&A
Ebola Vaccine Trials Carry Risks for Companies in Chase
Bloomberg
Tuesday, October 21, 2014 - 8:12am
tags:
ebola virus, vaccines, GSK, JNJ, NewLink Genetics
Ackman, Valeant lawyers say Allergan CEO oversaw campaign to discredit Valeant
Yahoo/Reuters
Tuesday, October 21, 2014 - 8:07am
tags:
Bill Ackman, Allergan, Valeant Pharmaceuticals, M&A, David Pyott
Actelion Says U.S. Tax-Inversion Limits Good for Industry
Bloomberg
Tuesday, October 21, 2014 - 8:05am
tags:
Actelion, tax inversions, M&A
What's behind the huge price jump for some generic drugs?
LA Times, CA
Tuesday, October 21, 2014 - 8:05am
tags:
generics, drug pricing
Celgene Crohn's drug trial successful
Yahoo/Investors Business Daily
Tuesday, October 21, 2014 - 8:02am
tags:
Celgene, Crohn's Disease, Mongersen
Allergan files rebuttal to Valeant earnings
Marketwatch
Monday, October 20, 2014 - 6:48pm
tags:
Allergan, Valeant Pharmaceuticals, earnings, M&A
Actavis Said to Compete With Sanofi for Omega Pharma Deal
Bloomberg
Monday, October 20, 2014 - 6:37pm
tags:
Actavis, Sanofi, Omega Pharma, M&A
AbbVie says $55 billion acquisition of Shire officially dead
Yahoo/Reuters
Monday, October 20, 2014 - 6:36pm
tags:
AbbVie, Shire, M&A, tax inversions
Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe?
Yahoo/Zacks.com
Monday, October 20, 2014 - 6:34pm
tags:
GSK, China, bribery, earnings
Paulson Urges Allergan/Shire Tie-up
WSJ Online
Monday, October 20, 2014 - 12:44pm
tags:
Allergan, Shire, M&A
Valeant may raise Allergan bid, says it won't walk away
Yahoo/Reuters
Monday, October 20, 2014 - 11:38am
tags:
Valeant Pharmaceuticals, Allergan, M&A
Baxter prepping for HyQvia launch with spinoff's success on the line
Fierce Pharma
Monday, October 20, 2014 - 11:36am
tags:
Baxter International, HyQvia, primary immunodeficiency

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.